Concord Wealth Partners’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.93K | Hold |
39
| – | – | ﹤0.01% | 636 |
|
|
2025
Q1 | $4.99K | Hold |
39
| – | – | ﹤0.01% | 584 |
|
|
2024
Q4 | $5.16K | Hold |
39
| – | – | ﹤0.01% | 596 |
|
|
2024
Q3 | $5.68K | Sell |
39
-4
| -9% | -$582 | ﹤0.01% | 616 |
|
|
2024
Q2 | $5.9K | Hold |
43
| – | – | ﹤0.01% | 557 |
|
|
2024
Q1 | $5.9K | Hold |
43
| – | – | ﹤0.01% | 634 |
|
|
2023
Q4 | $5.84K | Sell |
43
-39
| -48% | -$5.3K | ﹤0.01% | 622 |
|
|
2023
Q3 | $10K | Sell |
82
-21
| -20% | -$2.57K | ﹤0.01% | 616 |
|
|
2023
Q2 | $13.1K | Sell |
103
-6
| -6% | -$762 | ﹤0.01% | 569 |
|
|
2023
Q1 | $14.1K | Sell |
109
-162
| -60% | -$20.9K | ﹤0.01% | 547 |
|
|
2022
Q4 | $35.6K | Buy |
+271
| New | +$35.6K | 0.01% | 430 |
|
|
2022
Q3 | – | Sell |
-109
| Closed | -$13K | – | 595 |
|
|
2022
Q2 | $13K | Sell |
109
-119
| -52% | -$14.2K | ﹤0.01% | 633 |
|
|
2022
Q1 | $30K | Sell |
228
-57
| -20% | -$7.5K | 0.01% | 540 |
|
|
2021
Q4 | $43K | Buy |
285
+216
| +313% | +$32.6K | 0.01% | 479 |
|
|
2021
Q3 | $11K | Sell |
69
-55
| -44% | -$8.77K | ﹤0.01% | 456 |
|
|
2021
Q2 | $20K | Sell |
124
-100
| -45% | -$16.1K | 0.01% | 502 |
|
|
2021
Q1 | $34K | Buy |
224
+188
| +522% | +$28.5K | 0.01% | 394 |
|
|
2020
Q4 | $5K | Buy |
+36
| New | +$5K | ﹤0.01% | 416 |
|